Benefiting from the Human Genome | Anne Wojcicki

Monday, November 23, 2020

Benefiting from the Human Genome | Anne Wojcicki || Radcliffe Institute

Benefiting from the Human Genome
2020–2021 Kim and Judy Davis Dean's Lecture in the Sciences

In 2006, Anne Wojcicki cofounded 23andMe to help people access, understand, and benefit from the human genome, and she now serves as the company's CEO. In this Radcliffe Institute program, Wojcicki discusses the evolving benefits of genomic science, including the company's crowdsourced research platform. This platform has played a role in creating one of the largest COVID-19 research studies, exploring whether genetics plays a role in the severity or susceptibility to the virus, and is helping to drive the discovery of novel, genetically validated therapeutic targets to bring new medicines to patients.

Anne Wojcicki (5:43), cofounder and CEO, 23andMe

Jonathan Zittrain (26:09), George Bemis Professor of International Law and vice dean for library and information resources, Harvard Law School; faculty director, Berkman Klein Center for Internet & Society at Harvard University; professor of computer science, Harvard John A. Paulson School of Engineering and Applied Sciences; and professor, Harvard Kennedy School